A carregar...
Outcomes of her2-positive early-stage breast cancer in the trastuzumab era: a population-based study of Canadian patients
Breast cancer is heterogenous, with variable expression of the estrogen receptor (er), progesterone receptor (pr), and human epidermal growth factor receptor 2 (her2). Overexpression of her2 is generally considered a negative prognostic feature, but whether outcomes for her2-positive early breast ca...
Na minha lista:
| Main Authors: | , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Multimed Inc.
2013
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3851350/ https://ncbi.nlm.nih.gov/pubmed/24311954 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3747/co.20.1523 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|